A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Recruiting · NCT06389292 · Registry updated 2025-11-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2025-11-25 | NCT06389292 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Botkin Moscow Multidisciplinary Research and Clinical Center | Moscow | Russia | 1 |
| Hematology Hospital of the Chinese Academy of Medical Sciences | Tianjin | China | 4 |
| Leningrad Regional Clinical Hospital | Saint Petersburg | Russia | 2 |
| Moscow Multidisciplinary Clinical Center "Kommunarka" | Moscow | Russia | 3 |
| Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency | Saint Petersburg | Russia | 1 |
| The First Affiliated Hospital of Zhejiang University school of medicine | Hangzhou | China | 18 |